Ghent University Academic Bibliography

Your filters: cql: author="Mannent, Leda P" or (type any "bookEditor issueEditor" and editor="Mannent, Leda P")

Add to list
- Journal Article
- A1
- open access
Dupilumab improves health related quality of life : results from the phase 3 SINUS studies

Stella E Lee, Claire Hopkins, Joaquim Mullol, Jérôme Msihid, Isabelle Guillemin, Nikhil Amin, Leda P Mannent, Yongtao Li, Shahid Siddiqui, Chien Chia Chuang, et al.

(2022) ALLERGY. 77(7). p.2211-2221
Add to list
- Journal Article
- A1
- open access
Dupilumab improves health-related quality of life : results from the phase 3 SINUS studies

Stella E Lee, Claire Hopkins, Joaquim Mullol, Jérôme Msihid, Isabelle Guillemin, Nikhil Amin, Leda P Mannent, Yongtao Li, Shahid Siddiqui, Chien-Chia Chuang, et al.

(2022) ALLERGY. 77(7). p.2211-2221
Add to list
- Journal Article
- A1
Long-term safety and efficacy of dupilumab in patients with moderate-to-severe asthma (TRAVERSE) : an open-label extension study

Michael E Wechsler, Linda B Ford, Jorge F Maspero, Ian D Pavord, Alberto Papi, Arnaud Bourdin, Henrik Watz, Mario Castro, Natalia M Nenasheva, Yuji Tohda, et al.

(2022) LANCET RESPIRATORY MEDICINE. 10(1). p.11-25
Add to list
- Journal Article
- A1
- open access
Data mining of free-text responses : an innovative approach to analyzing patient perspectives on treatment for chronic rhinosinusitis with nasal polyps in a phase IIa proof-of-concept study for dupilumab

Asif H Khan, Adeline Abbe, Bruno Falissard, Paulo Carita, Claus Bachert (UGent) , Joaquim Mullol, Matthew Reaney, Jingdong Chao, Leda P Mannent, Nikhil Amin, et al.

(2021) PATIENT PREFERENCE AND ADHERENCE. 15. p.2577-2586
Add to list
Dupilumab reduces opacification across all sinuses and related symptoms in patients with CRSwNP

Claus Bachert (UGent) , S James Zinreich, Peter Hellings (UGent) , Joaquim Mullol, Daniel L Hamilos, Philippe Gevaert (UGent) , Robert M Naclerio, Nikhil Amin, Vikay N Joish, Chunpeng Fan, et al.

(2020) RHINOLOGY. 58(1). p.10-17
Add to list
Dupilumab improves health‐related quality of life in patients with chronic rhinosinusitis with nasal polyposis

Claus Bachert (UGent) , Peter Hellings (UGent) , Joaquim Mullol, Daniel L Hamilos, Philippe Gevaert (UGent) , Robert M Naclerio, Vijay N Joish, Jingdong Chao, Leda P Mannent, Nikhil Amin, et al.

(2020) ALLERGY. 75(1). p.148-157
Add to list
- Journal Article
- A1
Dupilumab improves nasal polyp burden and asthma control in patients with CRSwNP and AERD

Tanya M Laidlaw, Joaquim Mullol, Chunpeng Fan, Donghui Zhang, Nikhil Amin, Asif H. Khan, Jingdong Chao and Leda P Mannent

(2019) JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE. 7(7). p.2462-2465
Add to list
- Journal Article
- A1
- open access
Dupilumab reduces local type 2 pro-inflammatory biomarkers in chronic rhinosinusitis with nasal polyposis

Karin Jonstam, Brian N Swanson, Leda P Mannent, Lars-Olaf Cardell, Nian Tian, Ying Wang, Donghui Zhang, Chunpeng Fan, Gabriële Holtappels (UGent) , Jennifer D Hamilton, et al.

(2019) ALLERGY. 74(4). p.743-752
Add to list
- Journal Article
- A1
- open access
Dupilumab improves patient-reported outcomes in patients with chronic rhinosinusitis with nasal polyps and comorbid asthma

Claus Bachert (UGent) , Peter Hellings (UGent) , Joaquim Mullol, Robert M Naclerio, Jingdong Chao, Nikhil Amin, Annette Grabher, Brian N Swanson, Jennifer D Hamilton, Sophie Guillonneau, et al.

(2019) JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE. 7(7). p.2447-2449
Add to list
Efficacy and safety of dupilumab in patients with chronic rhinosinusitis with nasal polyps : results from the randomized phase 3 sinus-24 study

Joseph K Han, Claus Bachert (UGent) , Martin Desrosiers, Tanya M Laidlaw, Claire Hopkins, Wytske J Fokkens, Pierluigi Paggiaro, Seong Ho Cho, Heidi Olze, Leon S Greos, et al.

(2019) JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. 143(2, suppl.). p.AB422-AB422

Academic Bibliography

Dupilumab improves health related quality of life : results from the phase 3 SINUS studies

Dupilumab improves health-related quality of life : results from the phase 3 SINUS studies

Long-term safety and efficacy of dupilumab in patients with moderate-to-severe asthma (TRAVERSE) : an open-label extension study

Data mining of free-text responses : an innovative approach to analyzing patient perspectives on treatment for chronic rhinosinusitis with nasal polyps in a phase IIa proof-of-concept study for dupilumab

Dupilumab reduces opacification across all sinuses and related symptoms in patients with CRSwNP

Dupilumab improves health‐related quality of life in patients with chronic rhinosinusitis with nasal polyposis

Dupilumab improves nasal polyp burden and asthma control in patients with CRSwNP and AERD

Dupilumab reduces local type 2 pro-inflammatory biomarkers in chronic rhinosinusitis with nasal polyposis

Dupilumab improves patient-reported outcomes in patients with chronic rhinosinusitis with nasal polyps and comorbid asthma

Efficacy and safety of dupilumab in patients with chronic rhinosinusitis with nasal polyps : results from the randomized phase 3 sinus-24 study

Contents

Support

Contact